All patients | HRPE | p-value (HRPE versus nHRPE) | nHRPE | IRPE | p-value (IRPE versus LRPE) | LRPE | |
Subjects | 138 | 31 | 107 | 83 | 24 | ||
Thrombolysis | 56 (41) | 19 (61) | <0.01 | 37 (35) | 32 (39) | 0.17 | 5 (21) |
Surgery or intervention | 15 (10) | 4 (13) | 0.93 | 11 (10) | 8 (10) | 0.98 | 3 (12) |
Anticoagulation only | 67(49) | 8 (26) | 0.03 | 59 (55) | 43 (52) | 0.20 | 16 (67) |
30-day pulmonary embolism-related mortality | 26 (19) | 13 (42) | 0.0002 | 13 (12) | 13 (16) | 0.038 | 0 (0) |
30-day all-cause mortality | 34 (25) | 15 (48) | 0.0005 | 19 (18) | 17 (20) | 0.29 | 2 (8) |
Data are presented as n or n (%), unless otherwise stated. HRPE: high-risk pulmonary embolism; nHRPE: non-HRPE; IRPE: intermediate-risk pulmonary embolism; LRPE: low-risk pulmonary embolism.